Synthesis, in vitro-antimycobacterial activity and cytotoxicity of some alkyl α-(5-aryl-1,3,4-thiadiazole-2-ylthio)acetates

Archiv der Pharmazie

Volumn 338, Issue 2-3, 2005, Pages 112-116

  Foroumadi, Alireza ^a   Soltani, Fatemeh ^a   Moallemzadeh Haghighi, Hamideh ^a   Shafiee, Abbas ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,3,4 thiadiazole; Antituberculosis activity; Nitrofurans; Nitroimidazoles

Indexed keywords

METHYL ALPHA [5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; METHYL ALPHA [5 (5 NITRO 2 FURYL) 1,3,4 THIDIAZOL 2 YLTHIO]ACETATE; N BUTYL ALPHA [5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; N PROPYL ALPHA [5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; NITROFURAN DERIVATIVE; NITROIMIDAZOLE DERIVATIVE; PHENYLMETHYL ALPHA [5 (5 NITRO 2 FURYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CULTURE MEDIUM; DILUTION; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; VERO CELL;

ACETATES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; MICROBIAL SENSITIVITY TESTS; NITROIMIDAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP; THIADIAZOLES; VERO CELLS;

EID: 17844369446     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200400926     Document Type: Article

References (16)

1. J. M. Grang, A. Zumla, J. R. Soc. Health 2002, 122, 78-81.
2. T. Cohen, B. Sommers, M. Murrary, Lancet Infect. Dis. 2003, 3, 13-21.
3. H. Tomioka, Kekkaku 2002, 77, 573-584.
4. J. R. Pires, C. Saito, S. L. Gomes, A. M. Giesbrecht, A. T. Amaral, J. Med. Chem. 2001, 44, 3673-3681.
5. N. P. Mahmud, S. W. Garrett, M. D. Threadgill, Anticancer Drug Res. 1998, 13, 655-662.
6. N. S. Gunay, G. Capan, N. Ulusoy, N. Ergenc, G. Otuk, D. Kaya , Il Farmaco 1999, 54, 826-831.
7. R. Stoyanova, N. Kaloyanov, P. Traldi, M. Bliznakov, Arzneim. Forsch. 2001, 51, 991-997.
8. J. D. Maya, S. Bollo, L. J. Nunez-Vergara, J. A. Squella, Y. A. Repetto, A. Morello, J. Perie, G. Chauviere, Biochem. Pharm. 2003, 65, 999-1006.
9. M. Castelli, M. Malagoli , L. Lupo , S. Roffia, F. Paolucci, C. Cermelli, A. Zanca, G. Baggio, J. Antimicrob. Chemother. 2000, 46, 541-550.
10. M. G. Mamolo, L. Vio, E. Banfi, Il Farmaco 1996, 51, 71-74.
11. S. Rollas, S. Karakus, B. B. Durgun, M. Kiraz, H. Erdeniz, Il Farmaco 1996, 51, 811-814.
12. A. Tsotinis, A. Varvaresou, T. Calogeropoulou, T. Saiatra-Papastaikoundi, A. Tiligada, Arzneim. Forsch. 1997, 47, 307-310.
13. A. Foroumadi, M. Mirzaei, A. Shafiee, Pharmazie 2001, 56, 610-612.
14. A. Foroumadi, M. Mirzaei, A. Shafiee, Il Farmaco. 2001, 56, 621-624.
15. A. Foroumadi, M. Daneshtalab, A. Shafiee, Arzneim. Forsch. 1999, 49, 1035-1038.
16. L. Collins, S. G. Franzblan, Antimicrob. Agents Chemother. 1997, 41, 1004-1009.